LOS ANGELES – The West Coast Consortium for Technology and Innovation in Pediatrics has been awarded $6.6 million over five years by the U.S. Food and Drug Administration to continue its work in developing pediatric medical devices.
CTIP, based at Children’s Hospital Los Angeles and the University of Southern California, is one of five centers across the country awarded the FDA Pediatric Device Consortium grant offered by the Office of Orphan Products Development.
Established in 2011 and first funded by the FDA in 2013, CTIP promotes the commercialization and clinical use of pediatric medical device technology. The group fosters networking opportunities, direct and indirect financial support, and guidance on issues related to intellectual property, prototyping, engineering, testing, grant writing and clinical trial design—all on the road to getting the devices to market.
“Our mission is to improve health outcomes for our vulnerable pediatric population,” said Dr. Juan Espinoza, general pediatrician at Children’s Hospital Los Angeles and co-director of CTIP, in a statement. “To be recognized by the FDA as a center of excellence for pediatric innovation and to serve as a national resource for pediatric device development is both a great honor and great responsibility. We feel fortunate to be working with some of the finest institutions on the West Coast to support and foster collaboration in medical technology development.”
Over the past year, CTIP has focused on developing partnerships along the West Coast, bringing together a network of children’s hospitals, academic institutions, accelerators and incubators across California, Oregon and Washington. CTIP network members include the University of California, Los Angeles; Oregon Health & Science University; University of Southern California; University of California, San Diego; University of California, Berkeley; Seattle Children’s Hospital; Cedars-Sinai Accelerator; LA BioMed; and Project Zygote.
“We recognize that there are still many unmet needs facing pediatric patients, which motivates us to capitalize on our large network of multi-disciplinary stakeholders to identify and cultivate promising new technologies tailored to the needs of children,” said Dr. Yaniv Bar-Cohen, pediatric cardiologist at Children’s Hospital Los Angeles and co-director of CTIP, in a statement.
Since becoming an FDA-funded PDC, CTIP has supported 120 projects from 15 different states. As part of its second annual Catalyzing Pediatric Innovation Grant competition, CTIP recently awarded $235,000 in seed grants to six innovators developing new devices and technologies for young patients. The 2018 grant winners included a low-cost infant microbiome monitoring device for home or clinic use, a novel short arm exoskeleton to help treat orthopaedic fractures, an improved sound-delivery vest for treating respiratory conditions and a virtual reality system for treating pediatric chronic pain.
CHLA recently appointed its first-ever chief innovation officer, Omkar Kulkarni, with the goal of fostering innovation across CHLA’s clinical and research enterprises.
“Innovation in health care covers so much ground—from finding successful new methods of patient care to developing novel medical devices and digital health technologies—and the industry has yet to scratch the surface,” said Kulkarni in a statement. “Children’s Hospital Los Angeles has the expertise, experience and resources needed to lead the charge, and we are committed to pushing the boundaries of innovation to enhance the quality of care and health outcomes for the children we serve.”